Inicio › Esclerosis múltiple › Texas
Ensayos clínicos de Esclerosis múltiple en Texas
17 estudios sobre Esclerosis múltiple buscan participantes en Texas.
Ciudades en Texas
Texto oficial del estudio (inglés)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Austin
- TG Therapeutics Investigational Trial Site, Austin
- TG Therapeutics Investigational Trial Site, Austin
- y 6 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- y 2 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
- The University of Texas Health Science Center at Houston, Houston
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07606742Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
- The University of Texas at Dallas, Richardson
Reclutando
Edades de 18 a 65 · Todos los sexos · Actualizado el 15 sept 2026 · NCT05958381Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- ANESC Research- Site Number : 8400187, El Paso
- North Texas Institute of Neurology & Headache - Plano- Site Number : 8400082, Plano
- North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083, Plano
ReclutandoFase 3
Edades de 18 a 60 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dell Medical School, University of Texas at Austin, Austin
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0133, El Paso
ReclutandoFase 3
Edades de 10 a 17 · Todos los sexos · Actualizado el 10 sept 2026 · NCT06408259A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Local Institution - 0072, Lewisville
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 9 sept 2026 · NCT06782490Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
- University of Texas at Austin, Austin
Reclutando
Edades de 18 a 80 · Todos los sexos · Actualizado el 17 ago 2026 · NCT07759115Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
- UT Southwestern Medical Center (Ophthalmology CRU), Dallas
- Neuro-Eye Clinical Trials, Houston
ReclutandoFase 3
Edades de 18 a 50 · Todos los sexos · Actualizado el 14 ago 2026 · NCT07623668A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Carum Research, Dallas
- Saturn Research Solution, Plano
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 29 jul 2026 · NCT07225504A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
- University of Texas Southwestern Medical Center, Dallas
- ANESC Research, El Paso
- Saturn Research Solutions, Plano
ReclutandoFase 2
Edades de 18 a 55 · Todos los sexos · Actualizado el 15 jun 2026 · NCT06735248Care in Multiple Sclerosis (MS)
- Baylor College of Medicine, Houston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT07011914Non-invasive BCI-controlled Assistive Devices
- The University of Texas at Austin, Austin
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 80 · Todos los sexos · Actualizado el 1 may 2026 · NCT05183152Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
- Houston Methodist Hospital, Houston
Reclutando
Edades de 18 en adelante · Mujeres · Actualizado el 23 mar 2026 · NCT06072703Multiple Sclerosis Implementation Network (Registry)
- The University of Texas at Austin, Austin
- The University of Texas Health Science Center at Houston (UTHealth Houston), Houston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 feb 2026 · NCT07415824NARCOMS Registry: A Multiple Sclerosis Registry
- UT Southwestern Medical Center, Dallas
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2025 · NCT01018537De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.